Retatrutide1
Retatrutide is a triple receptor agonist peptide drug.
Retatrutide's Core Mechanism of Action (Triple Receptor Agonist) Unlike traditional weight-loss or blood sugar-lowering drugs, Retatrutide simultaneously activates the following three hormone receptors: 1. GLP-1 (Glucagon-like Peptide-1) Receptor: • Promotes insulin secretion and inhibits glucagon release, thereby lowering blood sugar. • Delays gastric emptying and enhances satiety, thereby suppressing appetite. 2. GIP (Glucose-dependent Insulin-stimulating Peptide) Receptor: • Synergistically enhances insulin secretion and glucose metabolism with GLP-1, and further optimizes adipose tissue metabolism. 3. GCG (Glucagon) Receptor: • Increases energy expenditure (increases metabolic rate). • Promotes lipolysis and reduces fat synthesis.
For laboratory research use only. Purity is the store's listed specification; published research is not batch certification.







